The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection
Open accessAbstract
Although 20%-40% of persons with acute hepatitis C virus (HCV) infection demonstrate spontaneous clearance, the time course and factors associated with clearance remain poorly understood. We investigated the time to spontaneous clearance and predictors among participants with acute HCV using Cox proportional hazards analyses. Data for this analysis were drawn from an international collaboration of nine prospective cohorts evaluating outcomes after acute HCV infection. Among 632 participants with acute HCV, 35% were female, 82% were Caucasian, 49% had interleukin-28 (IL28)B CC genotype (rs12979860), 96% had injected drugs ever, 47% were infected with HCV genotype 1, and 7% had human immunodeficiency virus (HIV) coinfection. Twenty-eight percent were HCV antibody negative/RNA positive at the time of acute HCV detection (early acute HCV). During follow-up, spontaneous clearance occurred in 173 of 632, and at 1 year after infection, 25% (95% confidence interval [CI]: 21, 29) had cleared virus. Among those with clearance, the median time to clearance was 16.5 weeks (IQR: 10.5, 33.4), with 34%, 67%, and 83% demonstrating clearance at 3, 6, and 12 months. Adjusting for age, factors independently associated with time to spontaneous clearance included female sex (adjusted hazards ratio [AHR]: 2.16; 95% CI: 1.48, 3.18), IL28B CC genotype (versus CT/TT; AHR, 2.26; 95% CI: 1.52, 3.34), and HCV genotype 1 (versus non-genotype 1; AHR: 1.56; 95% CI: 1.06, 2.30). The effect of IL28B genotype and HCV genotype on spontaneous clearance was greater among females, compared to males. Conclusions : Female sex, favorable IL28B genotype, and HCV genotype 1 are independent predictors of spontaneous clearance. Further research is required to elucidate the observed sex-based differences in HCV control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’hUigin, C., Kidd, J., Kidd, K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,150
Sex hormones and the immune response in humans
Bouman, A., Heineman, M. J., & Faas, M. M. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi008 · Cited by 1,131
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073
Micallef, J. M., Kaldor, J. M., & Dore, G. J. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00651.x · Cited by 871
Self-citationThe Xs and Y of immune responses to viral vaccines
Klein, S. L., Jedlicka, A., & Pekosz, A. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70049-9 · Cited by 815
Takaki, A., Wiese, M., Maertens, G., Depla, E., Seifert, U., Liebetrau, A., Miller, J. L., Manns, M. P., & Rehermann, B. (2000) · Nature Medicine · doi:10.1038/75063 · Cited by 739
Interferon signaling and treatment outcome in chronic hepatitis C
Sarasin-Filipowicz, M., Oakeley, E. J., Duong, F. H. T., Christen, V., Terracciano, L., Filipowicz, W., & Heim, M. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707882105 · Cited by 642
Marcello, T., Grakoui, A., Barba–Spaeth, G., Machlin, E. S., Kotenko, S. V., Macdonald, M. R., & Rice, C. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.052 · Cited by 561
Gerlach, J. T., Diepolder, H. M., Zachoval, R., Gruener, N. H., Jung, M.-C., Ulsenheimer, A., Schraut, W. W., Schirren, C. A., Waechtler, M., Backmund, M., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00668-1 · Cited by 524
Wiese, M., Berr, F., Lafrenz, M., Porst, H., & Oesen, U. (2000) · Hepatology · doi:10.1053/jhep.2000.8169 · Cited by 349
Tillmann, H. L., Thompson, A. J., Patel, K., Wiese, M., Tenckhoff, H., Nischalke, H. D., Lokhnygina, Y., Kullig, U., Göbel, U., Capka, E., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.005 · Cited by 322
Page, K., Hahn, J. A., Evans, J., Shiboski, S., Lum, P., Delwart, E., Tobler, L., Andrews, W., Avanesyan, L., Cooper, S., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/605947 · Cited by 285
Self-citationProspective Evaluation of Community‐Acquired Acute‐Phase Hepatitis C Virus Infection
Cox, A. L., Netski, D. M., Mosbruger, T., Sherman, S. G., Strathdee, S., Ompad, D., Vlahov, D., Chien, D., Shyamala, V., Ray, S. C., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/428578 · Cited by 231
Self-citationGrebely, J., Prins, M., Hellard, M., Cox, A. L., Osburn, W. O., Lauer, G., Page, K., Lloyd, A. R., & Dore, G. J. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70010-5 · Cited by 230
Self-citationHofer, H., Watkins-Riedel, T., Janata, O., Penner, E., Holzmann, H., Steindl-Munda, P., Gangl, A., & Ferenci, P. (2003) · Hepatology · doi:10.1053/jhep.2003.50019 · Cited by 203
Ray, S. C., Wang, Y.-M., Laeyendecker, O., Ticehurst, J. R., Villano, S. A., & Thomas, D. L. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2938-2946.1999 · Cited by 195
Wang, C. C., Krantz, E., Klarquist, J., Krows, M., McBride, L., Scott, E. P., Shaw‐Stiffel, T., Weston, S. J., Thiede, H., Wald, A., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/522608 · Cited by 186
Grebely, J., Petoumenos, K., Hellard, M., Matthews, G. V., Suppiah, V., Applegate, T., Yeung, B., Marks, P., Rawlinson, W., Lloyd, A. R., et al. (2010) · Hepatology · doi:10.1002/hep.23850 · Cited by 171
Self-citationPredicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men
Thomson, E. C., Fleming, V. M., Main, J., Klenerman, P., Weber, J., Eliahoo, J., Smith, J., McClure, M. O., & Karayiannis, P. (2011) · Gut · doi:10.1136/gut.2010.217166 · Cited by 161
Badr, G., Bédard, N., Abdel-Hakeem, M. S., Trautmann, L., Willems, B. E., Villeneuve, J., Haddad, E. K., Sékaly, R., Bruneau, J., & Shoukry, N. H. (2008) · Journal of Virology · doi:10.1128/jvi.01083-08 · Cited by 133
Self-citationSantantonio, T., Medda, E., Ferrari, C. I., Fabris, P., Cariti, G., Massari, M., Babudieri, S., Toti, M., Francavilla, R., Ancarani, F., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/507640 · Cited by 115
Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam
van de Laar, T. J. W., Molenkamp, R., van den Berg, C., Schinkel, J., Beld, M., Prins, M., Coutinho, R. A., & Bruisten, S. M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.027 · Cited by 106
Self-citationInduction and Evasion of Innate Antiviral Responses by Hepatitis C Virus
Lemon, S. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.099556 · Cited by 106
Page, K. A., Pappalardo, B. L., Tobler, L. H., Phelps, B. H., Edlin, B. R., Moss, A. R., Wright, T. L., Wright, D. J., OʼBrien, T. R., Caglioti, S., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01229-07 · Cited by 104
Self-citationvan den Berg, C. H. S. B., Grady, B. P. X., Schinkel, J., van de Laar, T. J. W., Molenkamp, R., van Houdt, R., Coutinho, R. A., van Baarle, D., & Prins, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027555 · Cited by 91
Self-citationFanning, L. J., Levis, J., Kenny-Walsh, E., Wynne, F., Whelton, M. J., & Shanahan, F. (2000) · Hepatology · doi:10.1053/jhep.2000.7437 · Cited by 74
Immunological determinants of the outcomes from primary hepatitis C infection
Post, J. J., Ratnarajah, S., & Lloyd, A. R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8270-4 · Cited by 58
Self-citationDoes the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type?
Harris, H., Eldridge, K. P., Harbour, S., Alexander, G., Teo, C., Ramsay, M. E., & The HCV National Register Steering Group (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00795.x · Cited by 56
Grebely, J., Morris, M. D., Rice, T., Bruneau, J., Cox, A. L., Kim, A. Y., McGovern, B., Shoukry, N. H., Lauer, G. M., Maher, L., et al. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys167 · Cited by 55
Self-citation
Cited by
Panel, A. H. G. (2015) · Hepatology · doi:10.1002/hep.27950 · Cited by 1,382
Natural history of hepatitis C.
Westbrook, R. H., & Dusheiko, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.012 · Cited by 1,049
Ghany, M. G., Morgan, T. R., & Panel, A. H. C. G. (2020) · Hepatology · doi:10.1002/hep.31060 · Cited by 955
Panel, A.-I. H. G., Chung, R. T., Ghany, M. G., Kim, A. Y., Marks, K. M., Naggie, S., Vargas, H. E., Aronsohn, A. I., Bhattacharya, D., Broder, T., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy585 · Cited by 717
Self-citationKoh, C., Li, Q., & Liang, J. (2016) · Clinical Virology · doi:10.1128/9781555819439.ch54 · Cited by 321
Metadata
- Authors
- Grebely, J., Page, K., Sacks-Davis, R., van der Loeff, M. S., Rice, T. M., Bruneau, J., Morris, M. D., Hajarizadeh, B., Amin, J., Cox, A. L., Kim, A. Y., McGovern, B. H., Schinkel, J., George, J., Shoukry, N. H., Lauer, G. M., Maher, L., Lloyd, A. R., Hellard, M., Dore, G. J., & Prins, M.
- Venue
- Hepatology
- Published
- 2014-01
- Volume
- 59
- Issue
- 1
- Pages
- 109-120
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2106110144
- Cited by
- 388
- References
- 30
- FWCI
- 23.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.